Comparison of the Effects of Desflurane, Sevoflurane, and Propofol on the Glottic Opening Area during Remifentanil-Based General Anesthesia Using a Supraglottic Airway Device
Table 1
Patient demographic and clinical characteristics.
Group D
Group S
Group P
value
n
30
30
30
Age (y)
50 ± 18
50 ± 17
49 ± 17
0.9556
Male : female
19 : 11
17 : 13
18 : 12
0.8703
Height (cm)
165 ± 9
163 ± 9
165 ± 10
0.6887
Body weight (kg)
65 ± 12
61 ± 12
66 ± 14
0.3258
% VC (%)
107 ± 20
111 ± 17
114 ± 19
0.4069
FEV1% (%)
86 ± 8
85 ± 6
84 ± 6
0.4055
History of asthma
1
1
1
>0.9999
Current smoker
5
3
6
0.5532
Mean remifentanil dose (μg/kg/min)
0.19 ± 0.03
0.21 ± 0.04
0.20 ± 0.04
0.2826
Mean dose of maintenance anesthetics
4.8 ± 1.3 (%)
1.6 ± 0.3 (%)
2.2 ± 0.3 (μg/ml)
—
Train-of-four ratio before inserting i-gel™ (%)
94 ± 23
90 ± 11
96 ± 13
0.3904
Surgical time (min)
164 ± 78
158 ± 60
160 ± 81
0.9487
Anesthesia time (min)
225 ± 82
223 ± 65
229 ± 89
0.9798
VC: vital capacity; FEV: forced expiratory volume. Usage of propofol is expressed as target-controlled infusion. Data are shown as mean ± SD.
